What alternative medication can be used instead of hydroxyzine in a 75‑year‑old patient with chronic obstructive pulmonary disease who is developing anticholinergic adverse effects such as double vision and altered mentation?

Discontinue Hydroxyzine Immediately and Consider Low-Dose Mirtazapine or Gabapentin as Safer Alternatives

This 75-year-old patient is experiencing classic anticholinergic toxicity (double vision and altered mentation) from hydroxyzine, which must be stopped immediately. The FDA label explicitly warns that elderly patients are particularly vulnerable to confusion and oversedation with hydroxyzine, and recommends starting at low doses with close observation 1. Your patient has clearly exceeded their tolerance threshold.

Why Hydroxyzine Must Be Stopped

Hydroxyzine is a strongly anticholinergic medication that falls squarely into the category of high-risk drugs that should be deprescribed in older adults according to Beers Criteria 2. The anticholinergic burden in elderly patients causes:

• Visual disturbances (your patient's double vision)
• Cognitive impairment (your patient's altered mentation)
• Increased fall risk
• Emergency department visits and hospitalizations
• Decline in functional status and activities of daily living 2, 3

The guideline evidence is unequivocal: older antihistamines like hydroxyzine have "strong anticholinergic effects" that are "usually poorly tolerated in aged patients" due to broad muscarinic receptor blockade 2.

Safe Alternatives for This Patient

First-Line Option: Low-Dose Mirtazapine (7.5 mg at bedtime)

• Minimal anticholinergic effects compared to hydroxyzine
• Sedating properties without the cognitive burden
• Additional benefit of appetite stimulation if needed
• Start at 7.5 mg and titrate cautiously

Second-Line Option: Gabapentin (100-300 mg at bedtime)

• No anticholinergic properties
• Effective for anxiety and sleep
• Requires renal dose adjustment in elderly patients
• Start low (100 mg) given age and monitor for dizziness

Third-Line Option: Trazodone (25-50 mg at bedtime)

• Lower anticholinergic burden than hydroxyzine
• Sedating at low doses
• Monitor for orthostatic hypotension
• Start at 25 mg

COPD Considerations

Good news: Hydroxyzine itself does not cause respiratory depression in COPD patients 4. The 1993 study demonstrated that even IV hydroxyzine at 1.5 mg/kg caused no significant changes in PaO2, PaCO2, or pH in COPD patients. However, this respiratory safety does NOT outweigh the severe anticholinergic toxicity your patient is experiencing.

The alternatives suggested above are also respiratory-safe:

• Mirtazapine: No significant respiratory depression
• Gabapentin: Safe in COPD
• Trazodone: Minimal respiratory effects at low doses

Critical Pitfalls to Avoid

1. Do not substitute with other first-generation antihistamines (diphenhydramine, chlorpheniramine) - these have identical or worse anticholinergic profiles 2

2. Avoid benzodiazepines - while tempting, they carry high fall risk and cognitive impairment in elderly patients

3. Do not use cyclobenzaprine or oxybutynin - these are also strongly anticholinergic medications explicitly mentioned as problematic 2

4. Start any alternative at the lowest possible dose - the FDA label emphasizes that elderly patients should start at low doses with close observation 1

Immediate Management Steps

1. Stop hydroxyzine immediately
2. Monitor for withdrawal (unlikely but possible after chronic use)
3. Assess for other anticholinergic medications in the patient's regimen - the "anticholinergic burden" from multiple drugs compounds toxicity 2, 3
4. Expect symptom improvement within 24-48 hours as hydroxyzine clears
5. Wait 2-3 days before starting alternative to ensure symptoms resolve and confirm hydroxyzine was the culprit

The patient's double vision and altered mentation should resolve within days of stopping hydroxyzine, confirming the diagnosis of anticholinergic toxicity.